IL-37 and IL-36 Cytokine Profiles in Chronic Hepatitis Delta During Bulevirtide Therapy.

Pathogens · 2026 · PMC12943429 · PMID 41754450

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Across the 48-week treatment period, IL-36β levels decreased in both cirrhotic and non-cirrhotic patients; however, these reductions did not reach statistical significance.

also in 111,027 other papers

a decreasing trendno p-value reported

A decreasing trend in IL-36β levels was observed in both VR and VNR patients over the 48-week treatment period, although this trend was not statistically significant.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.